Immune Anti-Inhibitors Regulate Immune Responses and Keep T Cells from Attacking Other Cells in the Body
Immune anti-inhibitors are a kind of cancer immunotherapy used to treat malignant melanoma. The treatment targets key regulators of your immune system, which when activated can dampen the immune defense response to an antigenic stimulus. Some cancers are able to protect themselves from attacks by suppressing immune checkpoint targets. When a tumor is suppressed the immune cells no longer attack the tumor, thereby not presenting an immunological response when it was important to do so. There are three types of immunotherapies: systemic, localized, and complementary. Systemic immunotherapy encompasses all strategies used to attack malignant tumors at the cellular level and include combination therapy and single cell genetic engineering. Locally designed immunotherapies include, interferon beta, lasers, drugs, and combinations of these. Complementary immunotherapy is used to enhance the immune defense of normal cells and tissues against biological agents. The most commonly